289
Views
5
CrossRef citations to date
0
Altmetric
Letter to the Editor: Original Scientific Contributions

Clinical manifestation and quantitative urinary analysis of N-ethylnorpentylone abuse in patients to the emergency department

, , , , &
Pages 935-937 | Received 23 Oct 2019, Accepted 09 Dec 2019, Published online: 28 Dec 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Te-I Weng, Hsien-Yi Chen, Lengsu W. Chin, Hsin-Hui Chou, Meng-Huan Wu, Guan-yuan Chen, Ju-Yu Chen, Chia-Pang Shih, Chih-Chuan Lin & Cheng-Chung Fang. (2022) Comparison of clinical characteristics between meth/amphetamine and synthetic cathinone users presented to the emergency department. Clinical Toxicology 60:8, pages 926-932.
Read now
Chih-Chuan Lin, Te-I Weng, Chip-Jin Ng, Chia-Pang Shih, Jui Hsu, Yuan-Chun Liao, Chen-Chang Yang & Cheng-Chung Fang. (2022) Emergency department visits due to new psychoactive substances and other illicit drugs in Taiwan: preliminary results of the Taiwan Emergency Department Drug Abuse Surveillance (TEDAS) project. Clinical Toxicology 60:6, pages 708-715.
Read now

Articles from other publishers (3)

Patryk Kuropka, Marcin Zawadzki & Paweł Szpot. (2022) A review of synthetic cathinones emerging in recent years (2019–2022). Forensic Toxicology 41:1, pages 25-46.
Crossref
Amanda L A Mohr, Barry K Logan, Melissa F Fogarty, Alex J Krotulski, Donna M Papsun, Sherri L Kacinko, Marilyn A Huestis & Jeri D Ropero-Miller. (2022) Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017–2020: A Review. Journal of Analytical Toxicology 46:6, pages e116-e185.
Crossref
Ju-Yu Chen, Guan-Yuan Chen, San-Yuan Wang, Cheng-Chung Fang, Lian-Yu Chen & Te-I Weng. (2022) Development of an analytical method to detect simultaneously 219 new psychoactive substances and 65 other substances in urine specimens using LC-QqQ MS/MS with CriticalPairFinder and TransitionFinder. Talanta 238, pages 122979.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.